Abstract:Protein–protein interactions (PPIs) play a crucial role in essential cellular functions including cell division, transmembrane signaling, and protein recognition. Abnormal PPIs have been linked to human diseases, either due to improper formation and/or stabilization of a protein complex or the failure of an essential interaction [1]. This has led to the emergence of PPIs as a promising target in modern drug discovery. However, modulation of PPIs by small molecules has traditionally been considered a challenging task. The PPI interface has been classified as ‘undruggable,’ because the PPI interface area usually tends to be large and flat with limited grooves or pockets, making it difficult for small molecules to bind [1,2]. Despite these serious challenges, there have been several recent advancements in PPI modulation. Seven PPI modulators have been approved by the FDA for the treatment of chronic lymphocytic leukemia, HIV, Merkel cell carcinoma, and nonsmall cell lung cancer. Additionally, 24 PPI modulators, including small molecules, peptides, and antibodies, are currently undergoing clinical trials [3]. These developments highlight the great potential of PPIs as drug discovery target(s). In silico techniques play an essential role in the design of modulators for PPIs [2,4,5]. These computational methods allow for the identification of PPI interfaces between proteins and the prediction of potential binding sites for modulators. Once a target region has been identified, various virtual screening strategies can be employed to identify lead compounds for further investigation. These lead compounds can be further optimized by analyzing the mode of interaction between compounds and protein interfaces. The recent advancements in artificial intelligence (AI) have dramatically improved the application of in silico techniques. The design of modulators targeting PPIs will definitely benefit from this. The purpose of this editorial is to provide a concise overview of the current and future directions of in silico design of PPI modulators, particularly in the context of the integration of AI. It would be expected that this area of research will continue to evolve as the fast development of AI and computing power. 2. Directions that should be focused in the future

Guiding biomolecular interactions in cells using de novo protein-protein interfaces

Synthetic Protein-Binding DNA Sponge As a Tool to Tune Gene Expression and Mitigate Protein Toxicity

Recent Progress Using De Novo Design to Study Protein Structure, Design and Binding Interactions

Maßgeschneiderte Liganden für Protein-Protein-Interaktionen

De novo design of protein interactions with learned surface fingerprints

Engineering conditional protein-protein interactions for dynamic cellular control

Redefining Protein Interfaces within Protein Single Crystals with DNA

Exploiting protein domain modularity to enable synthetic control of engineered cells

Computational Approaches for the Design of Modulators Targeting Protein-Protein Interactions

Modular and tunable biological feedback control using a de novo protein switch

Where to next in the evolution of in silico design of modulators targeting protein–protein interactions?

Engineering cell signaling modulators from native protein-protein interactions.

De novo protein design, a retrospective

De novo design of allosterically switchable protein assemblies

Exchange, promiscuity, and orthogonality in de novo designed coiled-coil peptide assemblies

Polymers for Disrupting Protein-Protein Interactions: Where Are We and Where Should We Be?

Nonnatural Protein–protein Interaction-Pair Design by Key Residues Grafting

DNA Origami-Based Protein Manipulation Systems: from Function Regulation to Biological Application.

Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids

Protein-Protein Interaction: Prediction, Design, and Modulation

Design and Selection of Heterodimerizing Helical Hairpins for Synthetic Biology